We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YMM icon
401
Full Truck Alliance
YMM
$9.83B
$103K ﹤0.01%
11,473
-385,717
-97% -$2.96M
GTM
402
ZoomInfo Technologies
GTM
$1.22B
$103K ﹤0.01%
10,000
-55,000
-85% -$576K
HLVX
403
DELISTED
HilleVax
HLVX
$91.1K ﹤0.01%
51,779
+4,809
+10% +$12.3K
SYF icon
404
PUT
Synchrony
SYF
$25.6B
$83.2K ﹤0.01%
21,900
– –
NBIX icon
405
PUT
Neurocrine Biosciences
NBIX
$16.7B
$72.8K ﹤0.01%
+30,000
New +$4.11M
VNO icon
406
PUT
Vornado Realty Trust
VNO
$7.38B
$72K ﹤0.01%
33,500
– –
IRTC icon
407
PUT
iRhythm Holdings
IRTC
$4.35B
$71.9K ﹤0.01%
+25,000
New +$1.99M
VKTX icon
408
CALL
Viking Therapeutics
VKTX
$3.9B
$68K ﹤0.01%
20,000
+6,400
+47% +$375K
NVO
409
PUT
Novo Nordisk
NVO
$209B
$67K ﹤0.01%
+10,000
New +$1.33M
ARVN icon
410
CALL
Arvinas
ARVN
$578M
$66K ﹤0.01%
+20,000
New +$522K
SYRS
411
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$65K ﹤0.01%
+113,000
New +$406K
TSLA icon
412
PUT
Tesla
TSLA
$1.29T
$64K ﹤0.01%
+50,000
New +$11.4M
CRSP icon
413
CALL
CRISPR Therapeutics
CRSP
$5.17B
$63.8K ﹤0.01%
30,000
+5,000
+20% +$254K
THO icon
414
PUT
Thor Industries
THO
$4.13B
$62.5K ﹤0.01%
+100,000
New +$10.2M
PRAX icon
415
PUT
Praxis Precision Medicines
PRAX
$10.1B
$60.6K ﹤0.01%
+25,000
New +$1.35M
INSM icon
416
CALL
Insmed
INSM
$28.1B
$50.3K ﹤0.01%
18,000
-42,000
-70% -$3.1M
SRPT icon
417
PUT
Sarepta Therapeutics
SRPT
$1.77B
$43.5K ﹤0.01%
10,000
-5,000
-33% -$691K
PRAX icon
418
CALL
Praxis Precision Medicines
PRAX
$10.1B
$41.6K ﹤0.01%
+13,000
New +$702K
CLBR.WS
419
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
$41.3K ﹤0.01%
129,160
-4,173
-3% -$1.43K
KRE icon
420
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.65B
$40.1K ﹤0.01%
+25,000
New +$1.37M
AGIO icon
421
CALL
Agios Pharmaceuticals
AGIO
$1.9B
$37.8K ﹤0.01%
20,000
-25,000
-56% -$1.14M
XAGEW
422
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$33K ﹤0.01%
371,250
– –
UBER icon
423
PUT
Uber
UBER
$153B
$31.8K ﹤0.01%
19,000
– –
MRNA icon
424
CALL
Moderna
MRNA
$22.5B
$30.9K ﹤0.01%
15,000
-1,000
-6% -$91.8K
ARKG icon
425
CALL
ARK Genomic Revolution ETF
ARKG
$1.69B
$29.8K ﹤0.01%
+70,000
New +$1.78M
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.